Skip to main content

Johnson & Johnson income statement

  • JNJ · NYSE
  • Healthcare
  • Pharmaceuticals
  • S&P 500
$285.75+0.79%Close 13 Nov 2026 · Market value $684.4B

Johnson & Johnson reported revenue of $94.2 billion for fiscal year 2025 (the twelve months to 28 Dec 2025), up 6.0% from fiscal 2024. Net income was $26.8 billion and diluted earnings per share $11.03.

From Johnson & Johnson's annual and quarterly reports, each period checked against accounting identities; a figure that does not pass is left blank. Fiscal years follow the company's calendar, the latest ending 28 Dec 2025. TTM is the last four reported quarters added up.

Annual

Johnson & Johnson income statement, annual
USDFY 2007FY 2008FY 2009FY 2010FY 2011FY 2012FY 2013FY 2014FY 2015FY 2016FY 2017FY 2018FY 2019FY 2020FY 2021FY 2022FY 2023FY 2024FY 2025TTM
Revenue$61.09B$63.75B$61.90B$61.59B$65.03B$67.22B$71.31B$74.33B$70.07B$71.89B$76.45B$81.58B$82.06B$82.58B$78.74B$79.99B$85.16B$88.82B$94.19B$99.33B
Revenue growth—+4.3%−2.9%−0.5%+5.6%+3.4%+6.1%+4.2%−5.7%+2.6%+6.3%+6.7%+0.6%+0.6%−4.7%+1.6%+6.5%+4.3%+6.0%—
Cost of revenue$17.75B$18.51B$18.45B$18.79B$20.36B$21.66B$22.34B$22.75B$21.54B$21.79B$25.44B$27.09B$27.56B$28.43B$23.40B$24.60B$26.55B$27.47B$30.26B$32.22B
Gross profit$43.34B$45.24B$43.45B$42.80B$44.67B$45.57B$48.97B$51.59B$48.54B$50.10B$51.01B$54.49B$54.50B$54.16B$55.34B$55.39B$58.61B$61.35B$63.94B$67.11B
Gross margin70.9%71.0%70.2%69.5%68.7%67.8%68.7%69.4%69.3%69.7%66.7%66.8%66.4%65.6%70.3%69.3%68.8%69.1%67.9%67.6%
Research and development——————————————$0.00$0.00$483.0M$1.84B$109.0M—
Selling, general and administrative$20.45B$21.49B$19.80B$19.42B$20.97B$20.87B$21.83B$21.95B$21.20B$20.07B$21.52B$22.54B$22.18B$22.08B$20.12B$20.25B$21.51B$22.87B$23.68B$25.50B
Operating income$13.58B$17.36B$16.21B$17.70B$13.77B$14.96B$16.41B$21.59B$19.75B$20.37B$18.18B$19.80B$19.81B$19.49B$19.83B$19.95B$21.21B$20.80B$25.29B$24.74B
Operating margin22.2%27.2%26.2%28.7%21.2%22.2%23.0%29.0%28.2%28.3%23.8%24.3%24.1%23.6%25.2%24.9%24.9%23.4%26.8%24.9%
Interest expense$296.0M$435.0M$451.0M$455.0M$571.0M$532.0M$482.0M$533.0M$552.0M$726.0M$934.0M$1.00B$318.0M$201.0M$183.0M$276.0M$772.0M$755.0M$971.0M$984.0M
Income before tax$13.28B$16.93B$15.76B$16.95B$12.36B$13.78B$15.47B$20.56B$19.20B$19.80B$17.67B$18.00B$17.33B$16.50B$19.18B$19.36B$15.06B$16.69B$32.58B$17.74B
Income tax expense$2.71B$3.98B$3.49B$3.61B$2.69B$3.26B$1.64B$4.24B$3.79B$3.26B$16.37B$2.70B$2.21B$1.78B$1.38B$2.99B$1.74B$2.62B$5.78B$1.64B
Effective tax rate20.4%23.5%22.1%21.3%21.8%23.7%10.6%20.6%19.7%16.5%92.6%15.0%12.7%10.8%7.2%15.4%11.5%15.7%17.7%9.3%
Net income$10.58B$12.95B$12.27B$13.33B$9.67B$10.85B$13.83B$16.32B$15.41B$16.54B$1.30B$15.30B$15.12B$14.71B$20.88B$17.94B$35.15B$14.07B$26.80B$16.09B
Net margin17.3%20.3%19.8%21.7%14.9%16.1%19.4%22.0%22.0%23.0%1.7%18.8%18.4%17.8%26.5%22.4%41.3%15.8%28.5%16.2%
EPS · diluted$3.63$4.57$4.40$4.78$3.49$3.86$4.81$5.70$5.48$5.93$0.47$5.61$5.63$5.51$7.81$6.73$13.72$5.79$11.03$6.58
Diluted weighted average shares2.9B2.8B2.8B2.8B2.8B2.8B2.9B2.9B2.8B2.8B2.7B2.7B2.7B2.7B2.7B2.7B2.6B2.4B2.4B2.4B
Basic weighted average shares2.9B2.8B2.8B2.8B2.7B2.8B2.8B2.8B2.8B2.7B2.7B2.7B2.6B2.6B2.6B2.6B2.5B2.4B2.4B2.4B
EBITDA$16.36B$20.20B$18.98B$20.64B$16.92B$18.62B$20.52B$25.48B$23.49B$24.13B$23.82B$26.73B$26.82B$26.72B$27.22B$26.93B$28.69B$28.14B$32.79B$32.83B
EBITDA margin26.8%31.7%30.7%33.5%26.0%27.7%28.8%34.3%33.5%33.6%31.2%32.8%32.7%32.4%34.6%33.7%33.7%31.7%34.8%33.0%
Depreciation & amortization$2.78B$2.83B$2.77B$2.94B$3.16B$3.67B$4.10B$3.90B$3.75B$3.75B$5.64B$6.93B$7.01B$7.23B$7.39B$6.97B$7.49B$7.34B$7.50B$8.09B
Stock-based compensation$698.0M$627.0M$628.0M$614.0M$621.0M$662.0M$728.0M$792.0M$874.0M$878.0M$962.0M$978.0M$977.0M$1.00B$1.14B$1.14B$1.16B$1.18B$1.35B$1.42B
Dividends per share$1.62$1.79$1.93$2.11$2.25$2.40$2.59$2.76$2.95$3.15$3.32$3.54$3.75$3.98$4.19$4.45$4.70$4.91$5.14$5.28

Quarterly

Johnson & Johnson income statement, quarterly
USDQ4 FY2023Q1 FY2024Q2 FY2024Q3 FY2024Q4 FY2024Q1 FY2025Q2 FY2025Q3 FY2025Q4 FY2025Q1 FY2026Q2 FY2026Q3 FY2026
Revenue$21.39B$21.38B$22.45B$22.47B$22.52B$21.89B$23.74B$23.99B$24.56B$24.06B$25.31B$25.40B
Cost of revenue$6.80B$6.51B$6.87B$6.96B$7.13B$7.36B$7.63B$7.30B$7.97B$8.11B$8.05B$8.10B
Gross profit$14.60B$14.87B$15.58B$15.51B$15.39B$14.54B$16.11B$16.69B$16.60B$15.96B$17.26B$17.30B
Gross margin68.2%69.6%69.4%69.0%68.3%66.4%67.9%69.6%67.6%66.3%68.2%68.1%
Selling, general and administrative$5.81B$5.26B$5.68B$5.48B$6.45B$5.11B$5.89B$5.92B$6.75B$6.03B$6.43B$6.29B
Operating income$4.19B$5.91B$6.28B$5.04B$3.58B$6.18B$6.65B$7.03B$5.43B$6.33B$7.14B$5.84B
Operating margin19.6%27.6%28.0%22.4%15.9%28.2%28.0%29.3%22.1%26.3%28.2%23.0%
Interest expense$151.0M$155.0M$270.0M$193.0M$137.0M$204.0M$308.0M$245.0M$214.0M$272.0M$281.0M$217.0M
Income before tax$4.83B$3.71B$5.75B$3.34B$3.89B$13.63B$6.49B$7.49B$4.97B$5.99B$6.75B$34.00M
Income tax expense$694.0M$459.0M$1.06B$644.0M$456.0M$2.63B$954.0M$2.34B−$150.0M$755.0M$1.21B−$176.0M
Effective tax rate14.4%12.4%18.5%19.3%11.7%19.3%14.7%31.2%−3.0%12.6%18.0%−518%
Net income$4.05B$3.25B$4.69B$2.69B$3.43B$11.00B$5.54B$5.15B$5.12B$5.24B$5.53B$210.0M
Net margin18.9%15.2%20.9%12.0%15.2%50.2%23.3%21.5%20.8%21.8%21.9%0.8%
EPS · diluted$1.67$1.34$1.93$1.11$1.41$4.54$2.29$2.12$2.09$2.14$2.27$0.09
Diluted weighted average shares2.4B2.4B2.4B2.4B2.4B2.4B2.4B2.4B2.4B2.4B2.4B2.4B
Basic weighted average shares2.4B2.4B2.4B2.4B2.4B2.4B2.4B2.4B2.4B2.4B2.4B2.4B
EBITDA$6.04B$7.72B$8.06B$6.88B$5.48B$7.95B$8.59B$8.81B$7.44B$8.33B$9.10B$7.96B
EBITDA margin28.2%36.1%35.9%30.6%24.3%36.3%36.2%36.7%30.3%34.6%36.0%31.3%
Depreciation & amortization$1.84B$1.81B$1.78B$1.85B$1.90B$1.77B$1.94B$1.78B$2.01B$2.00B$1.96B$2.12B
Stock-based compensation$178.0M$302.0M$341.0M$295.0M$238.0M$288.0M$410.0M$347.0M$309.0M$300.0M$458.0M$357.0M
Dividends per share$1.19$1.19$1.24$1.24$1.24$1.24$1.30$1.30$1.30$1.30$1.34$1.34

The main figures as JSON and plain text. See data and methodology.

JNJ in the terminal

Every line back twenty years, charts of any figure, segments and KPIs by quarter, valuation and alerts.